TEHRAN – Iran’s Vice President for Science and Technology Ruhollah Deghani and Venezuelan Science and Technology Minister Gabriela Serbia Jimenez discussed the development of cooperation on stem cells, nanotechnology, biotechnology, agriculture and livestock.
At a meeting in Tehran on Monday, Dehghani said Venezuela’s familiarity with Iran’s scientific and technological capabilities was a source of satisfaction and enhanced technical cooperation.
He said Venezuela is a country rich in natural resources and human capital, and expressed interest in enhancing cooperation in key areas of stem cells, nanotechnology, biotechnology, agriculture and livestock, and other strategic areas. said.
Knowledge-based enterprises have reached a stage where their role in the economy is inevitable, and bilateral interaction based on knowledge-based enterprises seems to be effective for the sustainable development of both countries, he said. explained.
The knowledge-based economy will reach real development in coordination and synergies between ministries and agencies, he said.
He pointed to the need for a needs-oriented and market-based innovation and technology house, and said Iran’s technology and innovation house in Venezuela was a key issue that triggered joint cooperation between the two countries.
He went on to point out that a need-oriented approach and awareness of market needs should be prioritized in these homes. And true development is formed when the markets and needs of each country are realized.
Jiménez also stepped up cooperation and expressed readiness to host Iranian scientists in Caracas, suggesting that Venezuelan scientists and researchers would be settled in Iranian scientific research centers.
A stem cell research center was recently established in Venezuela, the first in Latin America to perform a corneal stem cell transplant, she emphasized, adding that the center could make significant progress in the capabilities of Iranian scientists.
A visit to the Loyang Institute revealed that Iran has considerable capabilities in scientific and technological developments, especially in cell therapy, she stressed.
In September, more than 82 knowledge-based companies participated in the exhibition held in Caracas for the purpose of exchanging experiences and organizing meetings.
About 200 companies participated in the event and 60 cooperation contracts were signed. We tried to provide a space for interaction and synergy between companies, she said.
Venezuelan President Nicolas Maduro said in September that Iran today is an exemplary country, a country of progress, production, knowledge and production of goods.
Improving nanotech and biotech
One of the industries that has seen good growth in Iran in recent years is the nanotechnology industry, a sector that is testament to Iran’s scientific progress and has made Iran the fourth largest in the world.
Currently, nanotechnology products are produced and sold in more than 15 industrial fields based on domestic technology, and are exported to 49 countries on 5 continents.
Over the past year (to March 20), Iran’s total nanoproduct sales reached 115 trillion rials (approximately $425 million).
Expansion of the nanotechnology export program in recent years and the establishment of export hubs for nanotechnology products in China, India, Indonesia, Syria, Turkey, and Iraq will allow Iranian nanotechnology products, equipment and services to enter the global market. An opportunity has presented itself. .
About 42% of the products in this sector are related to construction, more than 17% to the oil, gas and petrochemical sector, 13% to the automotive sector and more than 10% to the optoelectronic sector. Related.
Today’s biotechnology is ubiquitous and no longer limited to biopharmaceuticals, it has replaced injured limbs.
In addition to kits, vaccines and blood products, 20 to 30 types of biopharmaceuticals are currently manufactured domestically. About 80% of biotech medicines are produced domestically.
Iran ranks 12th in the world and 1st in West Asia for biotechnology, with 9.5% of knowledge-based company income and more than 60% of exports related to biotechnology.